アステラス製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/09/02 | 1,820 | 1,820 | 1,783 | 1,792 | -25 | -1.4% | 3,628,200 |
2024/08/30 | 1,819.5 | 1,826 | 1,800.5 | 1,817 | -11 | -0.6% | 7,693,800 |
2024/08/29 | 1,819 | 1,835 | 1,814.5 | 1,828 | +13.5 | +0.7% | 5,467,400 |
2024/08/28 | 1,810 | 1,821 | 1,796 | 1,814.5 | -1.5 | -0.1% | 4,352,200 |
2024/08/27 | 1,794 | 1,816.5 | 1,789.5 | 1,816 | +21.5 | +1.2% | 4,172,900 |
2024/08/26 | 1,793 | 1,802 | 1,773.5 | 1,794.5 | -33 | -1.8% | 4,282,200 |
2024/08/23 | 1,816 | 1,827.5 | 1,807 | 1,827.5 | +11.5 | +0.6% | 6,488,600 |
2024/08/22 | 1,759.5 | 1,816 | 1,752 | 1,816 | +66 | +3.8% | 11,372,000 |
2024/08/21 | 1,730 | 1,759.5 | 1,726.5 | 1,750 | +38 | +2.2% | 8,680,300 |
2024/08/20 | 1,711.5 | 1,725 | 1,703 | 1,712 | +28.5 | +1.7% | 5,587,100 |
2024/08/19 | 1,716 | 1,716 | 1,678 | 1,683.5 | -32 | -1.9% | 5,475,600 |
2024/08/16 | 1,723 | 1,724 | 1,700 | 1,715.5 | +20 | +1.2% | 5,322,000 |
2024/08/15 | 1,674 | 1,701 | 1,668.5 | 1,695.5 | +17 | +1% | 4,777,000 |
2024/08/14 | 1,670.5 | 1,679.5 | 1,642.5 | 1,678.5 | +28.5 | +1.7% | 6,432,600 |
2024/08/13 | 1,623.5 | 1,650 | 1,623 | 1,650 | +19.5 | +1.2% | 7,812,200 |
2024/08/09 | 1,675 | 1,685.5 | 1,620 | 1,630.5 | -50 | -3% | 11,915,400 |
2024/08/08 | 1,663 | 1,701 | 1,650.5 | 1,680.5 | -13 | -0.8% | 5,602,000 |
2024/08/07 | 1,600 | 1,713.5 | 1,600 | 1,693.5 | +66.5 | +4.1% | 10,922,400 |
2024/08/06 | 1,676 | 1,722 | 1,584 | 1,627 | -9.5 | -0.6% | 17,489,700 |
2024/08/05 | 1,684.5 | 1,722 | 1,621 | 1,636.5 | -108.5 | -6.2% | 15,812,000 |
2024/08/02 | 1,734.5 | 1,762.5 | 1,695.5 | 1,745 | +31 | +1.8% | 18,644,600 |
2024/08/01 | 1,736.5 | 1,736.5 | 1,698 | 1,714 | -33.5 | -1.9% | 7,111,300 |
2024/07/31 | 1,732 | 1,749 | 1,719 | 1,747.5 | +18 | +1% | 9,633,600 |
2024/07/30 | 1,720 | 1,730 | 1,710.5 | 1,729.5 | +19 | +1.1% | 7,916,900 |
2024/07/29 | 1,698.5 | 1,714.5 | 1,687 | 1,710.5 | +21.5 | +1.3% | 7,789,200 |
2024/07/26 | 1,678 | 1,697.5 | 1,666 | 1,689 | +25 | +1.5% | 6,282,900 |
2024/07/25 | 1,660 | 1,669.5 | 1,641.5 | 1,664 | +4 | +0.2% | 5,379,100 |
2024/07/24 | 1,650 | 1,672 | 1,644.5 | 1,660 | +6 | +0.4% | 4,592,100 |
2024/07/23 | 1,642 | 1,656.5 | 1,638.5 | 1,654 | +17.5 | +1.1% | 3,627,400 |
2024/07/22 | 1,644 | 1,648 | 1,620.5 | 1,636.5 | -5.5 | -0.3% | 3,501,400 |
2024/07/19 | 1,657 | 1,663 | 1,625 | 1,642 | -55 | -3.2% | 9,695,600 |
2024/07/18 | 1,687 | 1,704 | 1,678 | 1,697 | +9 | +0.5% | 6,558,100 |
2024/07/17 | 1,667 | 1,697.5 | 1,665.5 | 1,688 | +33 | +2% | 6,754,100 |
2024/07/16 | 1,656 | 1,660 | 1,644 | 1,655 | -2 | -0.1% | 4,617,800 |
2024/07/12 | 1,655 | 1,664.5 | 1,647.5 | 1,657 | -5 | -0.3% | 6,881,900 |
2024/07/11 | 1,645 | 1,665 | 1,642.5 | 1,662 | +32 | +2% | 7,450,300 |
2024/07/10 | 1,625 | 1,632 | 1,612 | 1,630 | +0.5 | ±0% | 6,399,000 |
2024/07/09 | 1,612 | 1,635 | 1,606.5 | 1,629.5 | +20 | +1.2% | 5,509,000 |
2024/07/08 | 1,625 | 1,632 | 1,603.5 | 1,609.5 | -7 | -0.4% | 8,737,900 |
2024/07/05 | 1,615 | 1,623 | 1,604.5 | 1,616.5 | +12.5 | +0.8% | 6,136,600 |
2024/07/04 | 1,592 | 1,605 | 1,584 | 1,604 | +14 | +0.9% | 4,112,200 |
2024/07/03 | 1,585 | 1,595 | 1,583 | 1,590 | +2 | +0.1% | 4,632,300 |
2024/07/02 | 1,584 | 1,592 | 1,569 | 1,588 | -0.5 | ±0% | 6,589,400 |
2024/07/01 | 1,590.5 | 1,593 | 1,567 | 1,588.5 | -1.5 | -0.1% | 6,761,000 |
2024/06/28 | 1,605 | 1,609 | 1,585 | 1,590 | -9 | -0.6% | 8,161,300 |
2024/06/27 | 1,578 | 1,614 | 1,566 | 1,599 | +15 | +0.9% | 13,702,400 |
2024/06/26 | 1,575.5 | 1,599 | 1,567 | 1,584 | +5.5 | +0.3% | 8,991,800 |
2024/06/25 | 1,564.5 | 1,588 | 1,557.5 | 1,578.5 | +16 | +1% | 5,825,900 |
2024/06/24 | 1,542 | 1,566.5 | 1,536.5 | 1,562.5 | +33 | +2.2% | 6,467,800 |
2024/06/21 | 1,495 | 1,538 | 1,494 | 1,529.5 | +32.5 | +2.2% | 9,711,900 |
101~
150
件表示中 / 3631件
類似銘柄と比較する
現在ご覧いただいている「アステラス薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
アステラス薬 | 151,400円 | +18.5% | -96.0% | 4.89% | 193.61倍 | 1.77倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
武 田 | 420,900円 | +7.7% | +206.9% | 4.66% | 56.54倍 | 0.96倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
大塚HD | 813,600円 | +14.4% | +120.8% | 1.47% | 18.21倍 | 1.67倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
塩野義 | 229,000円 | +5.7% | +3.9% | 2.50% | 11.39倍 | 1.51倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 462,100円 | +1.7% | -2.9% | 3.46% | 30.32倍 | 1.59倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム